GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akanda Corp (NAS:AKAN) » Definitions » Gross-Profit-to-Asset %

Akanda (Akanda) Gross-Profit-to-Asset % : 0.00% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Akanda Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Akanda's annualized Gross Profit for the quarter that ended in Dec. 2023 was $0.00 Mil. Akanda's average Total Assets over the quarter that ended in Dec. 2023 was $22.67 Mil. Therefore, Akanda's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 0.00%.


Akanda Gross-Profit-to-Asset % Historical Data

The historical data trend for Akanda's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akanda Gross-Profit-to-Asset % Chart

Akanda Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
- -1.36 -0.03 13.90 0.46

Akanda Quarterly Data
Dec19 Sep20 Dec20 Jun21 Sep21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.17 - - - -

Competitive Comparison of Akanda's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Akanda's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akanda's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Akanda's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Akanda's Gross-Profit-to-Asset % falls into.



Akanda Gross-Profit-to-Asset % Calculation

Akanda's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=0.111/( (38.997+8.84)/ 2 )
=0.111/23.9185
=0.46 %

Akanda's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=0/( (36.508+8.84)/ 2 )
=0/22.674
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Akanda Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Akanda's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Akanda (Akanda) Business Description

Traded in Other Exchanges
Address
1A, 1B Learoyd Road, New Romney, GBR, TN28 8XU
Akanda Corp is a cannabis cultivation, manufacturing and distribution company. The Company has three reportable segments: Cultivation, Distribution and Corporate. Cultivating activities comprise the cultivation segment is made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.